GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
-4.96%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$4.86B
AUM Growth
-$412M
(-7.8%)
Cap. Flow
+$57.1M
Cap. Flow
% of AUM
1.18%
Top 10 Holdings %
Top 10 Hldgs %
32.54%
Holding
208
New
15
Increased
86
Reduced
85
Closed
22
Top Buys
| 1 |
Stratasys
SSYS
|
$59.7M |
| 2 |
Life Time Group Holdings
LTH
|
$59.3M |
| 3 |
Enovix
ENVX
|
$40.6M |
| 4 |
Chegg
CHGG
|
$32M |
| 5 |
Euronet Worldwide
EEFT
|
$30.6M |
Top Sells
| 1 |
Enphase Energy
ENPH
|
$52.7M |
| 2 |
Chart Industries
GTLS
|
$46.9M |
| 3 |
Workiva
WK
|
$37M |
| 4 |
Kornit Digital
KRNT
|
$30.1M |
| 5 |
Riskified
RSKD
|
$25.7M |
Sector Composition
| 1 | Technology | 37.42% |
| 2 | Healthcare | 18.43% |
| 3 | Industrials | 16.38% |
| 4 | Consumer Discretionary | 12.45% |
| 5 | Communication Services | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Xencor
XNCR
$615M
| $4.93M | 0.1% |
122,835
-4,899
| -4% | -$197K |
|
152
Arteris
AIP
$380M
| $4.78M | 0.1% |
+226,531
| New | +$4.78M |
|
153
Cytosorbents Corp
CTSO
$59.9M
| $4.63M | 0.1% |
1,105,607
-48,954
| -4% | -$205K |
|
154
Prothena Corp
PRTA
$449M
| $4.46M | 0.09% |
90,179
+44,875
| +99% | +$2.22M |
|
155
Cerus
CERS
$257M
| $4.4M | 0.09% |
645,565
-1,147,690
| -64% | -$7.82M |
|
156
Biomerica
BMRA
$7.63M
| $4.29M | 0.09% |
137,822
+8,902
| +7% | +$277K |
|
157
The Beauty Health Co
SKIN
$256M
| $4.19M | 0.09% |
173,224
-6,787
| -4% | -$164K |
|
158
CorVel
CRVL
$4.52B
| $4.13M | 0.09% |
59,541
-30,825
| -34% | -$2.14M |
|
159
AMN Healthcare
AMN
$786M
| $3.99M | 0.08% |
+32,604
| New | +$3.99M |
|
160
Trade Desk
TTD
$25.4B
| $3.99M | 0.08% |
43,503
-30,607
| -41% | -$2.81M |
|
161
Apellis Pharmaceuticals
APLS
$3.61B
| $3.95M | 0.08% |
+83,601
| New | +$3.95M |
|
162
Monolithic Power Systems
MPWR
$41.1B
| $3.79M | 0.08% |
7,685
-1,658
| -18% | -$818K |
|
163
Pliant Therapeutics
PLRX
$101M
| $3.69M | 0.08% |
+273,185
| New | +$3.69M |
|
164
CRISPR Therapeutics
CRSP
$4.82B
| $3.6M | 0.07% |
47,541
+2,211
| +5% | +$168K |
|
|
RVNC
165
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.53M | 0.07% |
216,497
+88,258
| +69% | +$1.44M |
|
166
CyberArk
CYBR
$23.4B
| $3.51M | 0.07% |
20,247
+755
| +4% | +$131K |
|
|
SWIR
167
DELISTED
Sierra Wireless
SWIR
| $3.37M | 0.07% |
191,508
-63,668
| -25% | -$1.12M |
|
|
PRTK
168
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.37M | 0.07% |
749,740
-71,914
| -9% | -$323K |
|
169
Editas Medicine
EDIT
$232M
| $3.32M | 0.07% |
125,183
+1,516
| +1% | +$40.3K |
|
170
Portillo's
PTLO
$495M
| $3.27M | 0.07% |
+87,053
| New | +$3.27M |
|
171
MacroGenics
MGNX
$131M
| $3.2M | 0.07% |
199,541
-31,517
| -14% | -$506K |
|
|
OLK
172
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $3.09M | 0.06% |
170,021
-15,809
| -9% | -$288K |
|
|
EVBG
173
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.88M | 0.06% |
+42,813
| New | +$2.88M |
|
174
Veritone
VERI
$155M
| $2.88M | 0.06% |
128,203
+36,253
| +39% | +$815K |
|
|
DMTK
175
DELISTED
DermTech, Inc. Common Stock
DMTK
| $2.32M | 0.05% |
147,095
+51,271
| +54% | +$810K |
|